Herpes Doctor

The short answer is not much for normal healthy individuals though for immunocompormised patients, HIV/AIDS would be the best example, there are several options. This article takes a brief look at those options and provides links to more extensive material.

From the Center for Disease Control and Prevention:

Currently, no treatment exists for CMV infection in the healthy individual. Antiviral drug therapy is now being evaluated in infants. Ganciclovir treatment is used for patients with depressed immunity who have either sight-related or life-threatening illnesses. Vaccines are still in the research and development stage.

HIV/AIDS and Immunocompromised Patients with CMV

CMV is hardly worth worrying about for most healthy people, however in HIV patients and otherwise immunocompromised individuals the infection can cause dramatic damage to the retina and other organs.

By far the most common complication of CMV in immunocompromised patients is Cytomegalovirus Retinitis: Where the CMV virus attacks the cells in the Retina causing severe vision loss or blindness if allowed to go unchecked. HIV patients with a CD4 cell count below 50 are at high risk from CMV

Ganciclovir - Used to Treat CMV in Immunocompromised Patients

Cytovene manufactured by Roche is the common brandname for Ganciclovir. It is administered orally, intraveneously and by direct injection in the eye.

If you have HIV, there is an excellent resource with detailed information on Cytomegalovirus here and a Cytovene PDF for download at Roche's website